Effects of Postbiotics on Mood Disorders in Korean Adults
NCT ID: NCT06982599
Last Updated: 2026-01-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
52 participants
INTERVENTIONAL
2025-10-13
2026-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Probiotics Therapy of Mood Disorders
NCT04753944
Effects of Prebiotics on Intestinal Colonization and Mood in a University Cohort
NCT05212545
Effect of Probiotic on Depression
NCT04567147
8-week of PS128 RCT in Patients With Major Depressive Disorder
NCT04199845
Effect of Two Probiotic Formulations on Mental Health and Mood Biomarkers in Adults With Depressive Symptoms
NCT05564767
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
postbiotics
3 capsules/day postbiotics (20 × 10\^9 CFU/day) for 8 weeks
postbiotics
3 capsules/day postbiotics (20 × 10\^9 CFU/day) for 8 weeks
Placebo
3 capsules/day placebo for 8 weeks
placebo
3 capsules/day placebo for 8 weeks
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
postbiotics
3 capsules/day postbiotics (20 × 10\^9 CFU/day) for 8 weeks
placebo
3 capsules/day placebo for 8 weeks
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* BMI between 18.5 and 30 at the time of screening.
* CES-D (Center for Epidemiologic Studies Depression Scale) score of 16 or higher.
* Ability to access and respond to the survey via an online link.
Exclusion Criteria
* History of antipsychotic medication treatment within the past 3 months before screening.
* Presence of chronic diseases, including cardiovascular, endocrine, immune, respiratory, hepatobiliary, renal and urological, neurological, musculoskeletal, inflammatory, hematological, oncological, or gastrointestinal disorders.
* Use of medications or health supplements related to gut health and mood disorders (e.g., antibiotics, laxatives, antidiarrheals, prebiotics, probiotics, postbiotics, anxiolytics, antidepressants, etc.) within 1 month prior to participation in the study.
* History of significant hypersensitivity to postbiotics or starch.
* Alcohol addiction, drug abuse, or suspicion of substance misuse.
* Pregnant or breastfeeding women.
* Any other reasons that the study investigator deems the participant unsuitable for participation.
19 Years
39 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
DSM-Firmenich AG
UNKNOWN
Hanyang University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Yongsoon Park
Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hanyang University
Seoul, Seoul, South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HYUIRB-202503-008
Identifier Type: OTHER
Identifier Source: secondary_id
POST-LB-KR
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.